Company Filing History:
3 out of 23 
2 out of 100 
1 out of 1 Years Active: 1993-1998
Title: **Patricia C. Augustine: Innovator in Avian Health**
Introduction
Patricia C. Augustine is an accomplished inventor based in Laurel, MD, whose remarkable contributions to the field of avian health are reflected in her six patents. Her innovative research focuses on creating vaccines and immunization methods to combat avian coccidiosis, a significant disease affecting poultry.
Latest Patents
Among her notable inventions is the patent for "Isolated protein from Eimeria useful as a cross species vaccine." This groundbreaking invention describes a cloned gene that encodes antigenic proteins capable of binding with monoclonal or polyvalent antibodies directed against avian coccidia. Furthermore, her patent on "Eimeria antigenic composition which elicits antibodies against avian" details novel recombinant antigenic proteins that contain antigenic determinants essential for immunizing chickens against avian coccidia. These innovations represent significant advancements in the development of effective vaccines for poultry.
Career Highlights
Throughout her career, Patricia has worked with prominent organizations such as the British Technology Group USA and Enzon, Inc. Her experience in these companies has contributed to her expertise in biotechnology and the development of vaccines, positioning her as a leading figure in avian health research.
Collaborations
Patricia's work has allowed her to collaborate with notable professionals in her field, including Susan L. Strausberg and Robert L. Strausberg. These collaborations have further enriched her research and have been instrumental in advancing the fight against avian diseases.
Conclusion
Patricia C. Augustine's innovative contributions have made a significant impact on the field of poultry health. Her dedication to developing effective vaccines against avian coccidiosis demonstrates her commitment to improving animal health and welfare. As she continues her work, her patents stand as a testament to her creativity and expertise in biotechnology.